{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/a4c5de36-8260-4222-8e38-ff997dc73436/6abe6660-ae64-4baa-adf2-03a7f4d9e5d2?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Companies & Markets Show 30 September 2016","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/61b9b44742e856e989985776/61b9b4cd24374a00129afd8f.png?height=200","description":"Good drugs and bad banks: In our 100th episode, editor John Hughman and the companies team talk about the bubbling drug discovery pipeline and the ongoing troubles of Europe's banking industry","author_name":"Investors' Chronicle"}